Generic Obesity Drugs Outshine Ivermectin Hoaxes in 2025 Health News
In 2025, the U.S. healthcare system is witnessing a defining shift. Generic obesity drugs approved by FDA are bringing science-backed hope...
Digital CME Growth Highlights Oncology Demand While Ivermectin Divides
In 2025, continuing medical education (CME) in the United States is experiencing a digital transformation. Online CME platforms are expanding rapidly...
